Cargando…
Hematopoietic Cell Transplantation for Primary Plasma Cell Leukemia: Results from the Center for International Blood and Marrow Transplant Research
There is limited data on hematopoietic cell transplantation (HCT) in primary plasma cell leukemia (pPCL), an aggressive plasma cell disorder. We report outcomes of 147 patients with pPCL receiving autologous (n=97) or allogeneic (n=50) HCT within 18 months after diagnosis between 1995 and 2006. Medi...
Autores principales: | Mahindra, Anuj, Kalaycio, Matt E., Vela-Ojeda, Jorge, Vesole, David H., Zhang, Mei-Jie, Li, Peigang, Berenson, James R., Bird, Jennifer M., Dispenzieri, Angela, Gajewski, James L., Gale, Robert P., Holmberg, Leona, Kumar, Shaji, Kyle, Robert A., Lazarus, Hillard M., Lonial, Sagar, Mikhael, Joseph, Milone, Gustavo A., Munker, Reinhold, Nath, Rajneesh, Saccaro, Steven, To, L Bik, Vogl, Dan T., Wirk, Baldeep, Hari, Parameswaran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3274611/ https://www.ncbi.nlm.nih.gov/pubmed/22042147 http://dx.doi.org/10.1038/leu.2011.312 |
Ejemplares similares
-
Early Relapse after Autologous Hematopoietic Cell Transplantation remains a Poor Prognostic Factor in Multiple Myeloma but Outcomes Have Improved Over Time
por: Kumar, Shaji K, et al.
Publicado: (2017) -
Autologous hematopoietic cell transplantation for multiple myeloma patients with renal insufficiency: A Center for International Blood and Marrow Transplant Research Analysis
por: Mahindra, Anuj, et al.
Publicado: (2017) -
Effect of acute and chronic graft-versus-host disease on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma
por: Ringdén, Olle, et al.
Publicado: (2011) -
Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation
por: Wirk, Baldeep, et al.
Publicado: (2013) -
Long-Term Outcome of Inflammatory Breast Cancer Compared to Non-Inflammatory Breast Cancer in the Setting of High-Dose Chemotherapy with Autologous Hematopoietic Cell Transplantation
por: Cheng, Yee Chung, et al.
Publicado: (2017)